Implantable Phakic Lens (IPCL) VS Implantable Collamer Lens
Launched by ASSIUT UNIVERSITY · Nov 5, 2020
Trial Information
Current as of June 28, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • myopia of more than 6 diopter
- • central anterior chamber depth more than 2.8 mm
- Exclusion Criteria:
- • unstable refraction
- • any other ocular disease
- • any systemic disease
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Asyut, , Egypt
Banhā, , Egypt
Patients applied
Trial Officials
Mahmoud F Rateb, MD
Principal Investigator
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials